Word

MEDPRO SYSTEMS

Status

Pending

Status Code

681

Status Date

Tuesday, March 12, 2024

Serial Number

98048406

Mark Type

3000

Filing Date

Monday, June 19, 2023

Published for Opposition

Tuesday, April 16, 2024

Trademark Owner History

MedPro Systems LLC

Classifications

41 Consulting services in the nature of conducting trainings for life sciences, pharmaceuticals, biotechnology, and medical device companies personnel and partners on pharmaceutical and medical device compliance program requirements, fraud and corruption laws and regulations, industry codes and best practices; consulting services, namely, developing and providing trainings for life sciences, pharmaceutical, biotechnology, and medical device companies in the field of corporate compliance and transparency programs

35 Business consulting services for life sciences, pharmaceuticals, biotechnology and medical device companies in the nature of regulatory compliance program development and enhancement and transparency program support, namely, reviewing program status and performing gap analyses, drafting programs plans, program implementation support, development and improvement of policies, standard operating procedures and codes of conduct; business consulting services in the nature of monitoring of pharmaceutical and medical device manufacturer interactions with healthcare professionals, healthcare organizations, patients, and other customers; business consulting services in the nature of auditing of pharmaceutical and medical device manufacturer interactions with and payments to healthcare professionals, healthcare organizations, patients, and other customers; business consulting services in the nature of business investigation support for internally and externally raised complaints made against a pharmaceutical or medical device manufacturer related to potential violations of their company policy or code, industry code, or law or regulation; transparency reporting regulatory submission management, namely, assisting others in preparing and filing regulatory submissions in the field of transparency reporting for pharmaceutical, biotechnology and medical device companies; business consulting services, namely, tracking and monitoring regulatory requirements for others in the field of life sciences, pharmaceuticals, biotechnology, and medical devices for regulatory compliance; business consulting services, namely, compliance program gap analysis for life sciences, pharmaceutical, biotechnology, and medical device companies

45 Regulatory compliance consulting in the field of life sciences, pharmaceuticals, biotechnology, and medical devices; consulting services to assist life sciences, pharmaceutical, biotechnology and medical device companies in the fields of regulatory compliance, namely, compliance in the areas of aggregate spend disclosure reporting, the Prescription Drug Marketing Act, the Drug Supply Chain Security Act, Condition of Participation for Outpatient Services, Stark Law and Ohio Terminal Distributor of Dangerous Drugs requirements; regulatory compliance audits for life sciences, pharmaceutical, biotechnology and medical device companies to assist with regulatory compliance; consulting services in the field of life sciences, pharmaceutical, biotechnology and medical device corporate compliance program and transparency program development, implementation and support; providing online searchable databases and information concerning historical, current and pending laws, regulations, and guidance documents governing the life sciences industry; regulatory compliance consulting services in the field of aggregate spend disclosure reporting; regulatory and compliance information for pharmaceutical, biotechnology and medical device companies, and for entities involved in the drug and device supply chain, regarding transparency and aggregate spend, marketing, and additional compliance requirements; regulatory compliance consulting, namely, reviewing, developing, training on and assisting with the implementation and monitoring of standards, practices, procedures and policies to support regulatory compliance for companies in the fields of life sciences, pharmaceuticals, biotechnology, and medical devices

42 Software as a service (SaaS) services featuring software for use to assist in tracking and reporting healthcare practitioner and healthcare organization interactions and complying with international, federal, state and local spend and transparency laws and regulations; software as a service (SaaS) services featuring software to assist pharmaceutical, biotechnology and medical device companies in managing, validating and enriching healthcare organization and healthcare practitioner data attributes in connection with regulatory compliance, sales and marketing efforts

The mark consists of a rectangle consisting of two interlocking puzzle pieces. The puzzle piece on the left is gray and contains the word "MEDPRO" in white, and the puzzle piece on the right is navy blue and contains the word "SYSTEMS" in white.
The colors blue, gray and white are claimed as a feature of the mark.
"SYSTEMS"

Trademark Events

Mar 27, 2024

Notification Of Notice Of Publication E-Mailed

Mar 11, 2024

Approved For Pub - Principal Register

Mar 5, 2024

Teas/Email Correspondence Entered

Mar 5, 2024

Correspondence Received In Law Office

Mar 5, 2024

Teas Response To Office Action Received

Mar 1, 2024

Notification Of Non-Final Action E-Mailed

Mar 1, 2024

Non-Final Action E-Mailed

Mar 1, 2024

Non-Final Action Written

Feb 26, 2024

Assigned To Examiner

Jul 22, 2023

Notice Of Design Search Code E-Mailed

Jul 21, 2023

New Application Office Supplied Data Entered

Jun 22, 2023

New Application Entered